An assessment of nucleic acid amplification testing for active mycobacterial infection



Yüklə 3,88 Mb.
səhifə37/143
tarix04.01.2022
ölçüsü3,88 Mb.
#60347
1   ...   33   34   35   36   37   38   39   40   ...   143
Element of clinical question

Search terms

Population

(“mycobacterium nontuberculous” OR “Mycobacterium Infections, Nontuberculous” [MeSH] OR “environmental mycobacteria” OR “mycobacteria other than tuberculosis” OR MOTT OR NTM OR NTMB OR “M. abscessus” OR “M avium” OR “M. chelonae” OR “M. flavescens” OR “M. fortuitum” OR “M. genavense” OR “M. gordonae” OR “M. haemophilum” OR “M. intracellulare” OR “M. kansasii” OR “M. malmoense” OR “M. marinum” OR “M. peregrinum” OR “M. scrofulaceum” OR “M. simiae” OR “M. smegmatis” OR “M. szulgai” OR “M. terrae” OR “M. ulcerans” OR “M. xenopi”)

Intervention

(Amplicor OR Amplified OR “Direct Test” OR “Direct Detection” OR Xpert OR TaqMan OR “nucleic acid amplification” OR NAAT OR “polymerase chain reaction” OR PCR OR “Nucleic Acid Amplification Techniques” [MeSH])

Comparator (if applicable)

N/A

Outcomes (if applicable)

N/A

Limits

1990 – June 2014; NOT (Other Animals NOT Humans)

MeSH = Medical Subject Heading, based on a Medline/PubMed platform; N/A = not applicable

Table Search terms used for impact of early identification of drug resistance and alternative treatment




Yüklə 3,88 Mb.

Dostları ilə paylaş:
1   ...   33   34   35   36   37   38   39   40   ...   143




Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©muhaz.org 2024
rəhbərliyinə müraciət

gir | qeydiyyatdan keç
    Ana səhifə


yükləyin